High hyperdiploid karyotype with ≥ 49 chromosomes represents a heterogeneous subgroup of acute myeloid leukemia with differential TP53 mutation status and prognosis: a single-center study from China Zhiyu ZhangChunmei FuJinlan Pan Research 08 June 2024
Targeting histone deacetylase 1 (HDAC1) in the bone marrow stromal cells revers imatinib resistance by modulating IL-6 in Ph + acute lymphoblastic leukemia Danna WeiXiaoling LiangJingrong Zhang Research 07 June 2024
Prognostic impact of 1q abnormality on outcomes in patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide and dexamethasone in a real-world clinical setting Taku KikuchiNobuhiro TsukadaTadao Ishida Correspondence 06 June 2024
Association of routine hematological parameters with the development of monoclonal gammopathies: a case-control study of 134,740 patients Jakob Røllum-LarsenAnna Elise EngellHenrik Løvendahl Jørgensen Research Open access 06 June 2024
Switching from eltrombopag to hetrombopag in patients with primary immune thrombocytopenia: a post-hoc analysis of a multicenter, randomized phase III trial Heng MeiXiaofan LiuYu Hu Research Open access 06 June 2024
Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy Anthi BouchlaChristina D. SotiropoulouVasiliki Pappa Research Open access 06 June 2024
Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients Shuang WuJie ZhangTingxun Lu Original Article 06 June 2024
Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities Betül BudakEzgi Yağmur TükelYağmur Kiraz Research Open access 05 June 2024
Lymphocyte profile in peripheral blood of patients with multiple myeloma Tereza DekojováHana GmucováMonika Holubová Research 04 June 2024
Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p Boyang ZhengYueqi GengAichun Liu Research 03 June 2024
Reduced intensity conditioning regimen of fludarabine, busulfan, ATG based haploidentical stem cell transplantation for older or unfit patients Mingyue PanYibo WuYi Luo Research 03 June 2024
Effective management of heparin-resistant thrombosis: a case study on rivaroxaban therapy guided by thromboelastography Chuandong HouBing ZhaiXueChun Lu Letter to the Editor 01 June 2024
Immunophenotypic classification regarding prognosis in peripheral T cell lymphoma, NOS, and nodal T follicular helper T cell lymphoma, angioimmunoblastic-type Soyeon ChoiJae-Cheol JoHee Jeong Cha Research 30 May 2024
Chemotherapy vs. “TKI + immunotherapy” in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene Yan LiQin ZhangHaigang Shao Correspondence 29 May 2024
BeEAM vs. BEAM: evaluating conditioning regimens for autologous stem cell transplantation in patients with relapsed or refractory DLBCL Ruiqi WangXinghe ShangguanWenlong Zhang Research 29 May 2024
Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients Peipei YeMengjie WuYing Lu Research 29 May 2024
Pediatric acute myeloid leukemia with t(8;21) and KIT mutation treatment with avapritinib post-stem cell transplantation: a report of four cases Qingwei WangYixin HuShaoyan Hu Case Report Open access 28 May 2024
Daratumumab-based regimens for patients with multiple myeloma plus extramedullary plasmacytomas or paraskeletal plasmacytomas: initial follow-up of an Italian multicenter observational clinical experience Giuseppe MeleDaniele DerudasDomenico Pastore Research 28 May 2024
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China Wei WangWei ZhangDao-bin Zhou Original Article 28 May 2024
Blinatumomab-induced macrophage activating syndrome (MAS) in adult with B-cell acute lymphoblastic leukemia (B-ALL) Adam BraunSalman OtoukeshIbrahim Aldoss Case Report Open access 24 May 2024
Acute myeloid leukemia with paraneoplastic pemphigus successfully treated with a personalized antileukemic and immunosuppressive strategy Francesca Romana IoveneEnrico SantinelliLuigi Rigacci Case Report 23 May 2024
Flow-cytometry Assessment of DNA content and Immunophenotyping of Immune-cells in Lymph-node-specimens as a Potential Diagnostic Signature of Aggressiveness in B-Non-Hodgkin Lymphomas David AzoulayTal TapuchiNetanel A. Horowitz Research Open access 23 May 2024
A preliminary study of roxadustat in the treatment of aplastic anemia patients with inadequate erythroid responses Yimeng ShiYufei ZhaoFengkui Zhang Research Open access 22 May 2024
Real-life use of ropeg-interferon α2b in polycythemia vera: patient selection and clinical outcomes Francesca PalandriF. BranzantiM. Cavo Research Open access 21 May 2024
The effectiveness of the doxorubicin-etoposide-methylprednisolone regimen for adult HLH secondary to rheumatic disease Dongfei YinJingshi WangZhao Wang Research 21 May 2024
Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR) José Manuel Marco SánchezEduardo Jesús Bardón CanchoElena Cela Research Open access 20 May 2024
Neurological involvement in hematopoietic stem cell transplantation-associated thrombotic microangiopathy Wanying LiuXiaojian ZhuYi Xiao Review Article Open access 20 May 2024
STK10 mutations block erythropoiesis in acquired pure red cell aplasia via impairing ribosome biogenesis Jichun YangXiaofeng ShiZhangbiao Long Research 18 May 2024
Clinical characteristics and prognosis of patients with newly diagnosed primary central nervous system lymphoma: a multicentre retrospective analysis Si-Jun BaiJian-Xia HeLin-Hua Yang Research 18 May 2024
Impact of cladribine, cytarabine, and G-CSF (CLAG) as a bridging therapy prior to allogeneic hematopoietic stem cell transplantation in relapsed or refractory acute myeloid leukemia Tong CuiHuiyu LiXiaojin Wu Original Article 17 May 2024
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia Yukinori NakamuraYoshitaka ZaimokuYasushi Onishi Research 16 May 2024
Treatment of primary cardiac diffuse large B-cell lymphoma involving the coronary sinus with R-EPOCH: a case report and literature review Aryan RezvaniShilpan Shah Case Report 15 May 2024
Genetic variability profiling of the p53 signaling pathway in chronic lymphocytic leukemia. Individual and combined analysis of TP53, MDM2 and NQO1 gene variants María Belén FontechaMaría Del Rosario AnadónAriela Freya Fundia Research 14 May 2024
Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA Zhexuan TangDesheng ZhuXiulan Lu Original Article 13 May 2024
Comprehensive procedure for injecting Evusheld® for hematological diseases in a single institute Osamu ImatakiShunsuke YoshidaNorimitsu Kadowaki Original Research 12 May 2024
Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia Markus TölleNicola GökbugetStefan Schwartz Letter to the Editor Open access 11 May 2024
Optimization of immune checkpoint inhibitor treatment planning for relapsed or refractory extranodal NK/T cell lymphoma Sang Eun YoonHyungwoo ChoWon Seog Kim Research 11 May 2024
DNT cells mediate resistance to CAR-T cells therapy in a pediatric patient with relapsed and refractory B-ALL Ruotong ChenQianshan TaoHuiping Wang Case Report 10 May 2024
Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients Yu ShiXiao ChenChun Qiao Original Article 09 May 2024
A systematic review and meta-analysis of the morbidity of efficacy endpoints and bleeding events in elderly and young patients treated with the same dose rivaroxaban Jianwei RenNa WangXiaohong Han Review 07 May 2024
Aberrant ecotropic viral integration site-1 (EVI-1) and myocyte enhancer factor 2 C gene (MEF2C) in adult acute myeloid leukemia are associated with adverse t (9:22) & 11q23 rearrangements Nadia El MenshawyMohamed S. El-GhonemyShaimaa El-Ashwah Research Open access 07 May 2024
Inflammation mediated angiogenesis in chronic lymphocytic leukemia Olivera Mitrović-AjtićEmilija ŽivkovićVladan P. Čokić Original Article 07 May 2024
Risk factors and survival outcomes in children with early cardiotoxicity after allogeneic hematopoietic stem cell transplantation Ke TongYan MengYing Dou Research 06 May 2024
Latent tuberculosis infection detected by quantiferon-TB assay in patients with multiple myeloma receiving novel drugs: focus on reactivation prophylaxis in a retrospective, single-center study Nicola SgherzaPaola CurciPellegrino Musto Correspondence 04 May 2024
Economic evaluation of anti-CD19 CAR T-cell pathway for large B-cell lymphomas in the real-life setting: the experience of an Italian hub center in the first three years of activity Rossana Di StasoBeatrice CasadeiLisa Argnani Research Open access 02 May 2024
Combining serum microRNAs and machine learning algorithms for diagnosing infectious fever after HSCT Wenwei ShaoYixuan WangXiaolei Pei Research 01 May 2024 Pages: 2089 - 2102
Sirolimus is effective for refractory/relapsed idiopathic multicentric Castleman disease: A single-center, retrospective study Yan-ting LiuYu-han GaoLu Zhang Research 01 May 2024
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience Nicolò DanesinLaura BonaldiFrancesco Piazza Research Open access 30 April 2024
Advances in hematopoietic stem cells ex vivo expansion associated with bone marrow niche Ju DengYanhong TanHongwei Wang Review Article 30 April 2024